Danish researchers have created new cell lines that need a less tailored feeding schedule and produce fewer waste products.
Technologies used for cell and gene therapy development have come a long way but there are still important challenges associated with lentivirus manufacture. GMP plasmids account for a substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results